Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT
Focused on developing treatments for rare diseases associated with vascular malformationsRecruited first patients in Proof-of-Concept study for le...
Source: businessinsider.com